These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1885117)

  • 1. [Lipid metabolism disorder: detection and treatment. 5: Treatment of hyperlipidemia in manifest coronary heart disease, diabetes mellitus and hypertension. National cholesterol initiative].
    Assmann G
    Fortschr Med; 1991 Jun; 109(17):361-3. PubMed ID: 1885117
    [No Abstract]   [Full Text] [Related]  

  • 2. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease.
    Perreault S; Dorais M; Coupal L; Paradis G; Joffres MR; Grover SA
    CMAJ; 1999 May; 160(10):1449-55. PubMed ID: 10352634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C; Olsson AG
    Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
    Ravindran R; Krishnan LK
    Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inborn errors of lipid metabolism. XIX. Basic principles of complex therapy of hyperlipoproteinemias].
    Sobra J
    Cas Lek Cesk; 1970 May; 109(21):457-63. PubMed ID: 4987971
    [No Abstract]   [Full Text] [Related]  

  • 7. Achievement of guideline-defined treatment goals in primary care: the German Coronary Risk Management (CoRiMa) study.
    Geller JC; Cassens S; Brosz M; Keil U; Bernarding J; Kropf S; Bierwirth RA; Lippmann-Grob B; Schultheiss HP; Schlüter K; Pels K
    Eur Heart J; 2007 Dec; 28(24):3051-8. PubMed ID: 18029365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [To normalize the lipidogram. Why, how, and how much?].
    Azevedo Ade C
    Arq Bras Cardiol; 1995 Feb; 64(2):145-8. PubMed ID: 7575161
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis and treatment of primary hyperlipidemia in childhood. A Joint Statement for Physicians by the Committee on Atherosclerosis and Hypertension in Childhood of the Council of Cardiovascular Disease in the Young and the Nutrition Committee, American Heart Association.
    Circulation; 1986 Nov; 74(5):1181A-1188A. PubMed ID: 3769175
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypercholesterolemia in patients with hypertension and diabetes mellitus. The need for cholesterol control in the prevention of ischemic heart disease].
    Heyden S
    Wien Med Wochenschr; 1986 Sep; 136(17):437-42. PubMed ID: 3798928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).
    Gudbjörnsdottir S; Eeg-Olofsson K; Cederholm J; Zethelius B; Eliasson B; Nilsson PM;
    Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for macrovascular disease in type 2 diabetes. Classic lipid abnormalities.
    Steiner G
    Diabetes Care; 1999 Apr; 22 Suppl 3():C6-9. PubMed ID: 10189556
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetic dyslipidemia: a case for aggressive intervention in the absence of clinical trial and cost effectiveness data.
    Lewis GF
    Can J Cardiol; 1995 May; 11 Suppl C():24C-28C. PubMed ID: 7750045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of plasma hormones and lipids in healthy elderly Thais compared to patients with chronic diseases: diabetes mellitus, essential hypertension and coronary heart disease.
    Chearskul S; Charoenlarp K; Thongtang V; Nitiyanant W
    J Med Assoc Thai; 2000 Mar; 83(3):266-77. PubMed ID: 10808681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of lipid metabolism disorders in the elderly].
    Mizera W; Grzeszczak W
    Wiad Lek; 1998; 51 Suppl 2():52-7. PubMed ID: 9686534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Coronary disease. Prevention and current therapeutic concepts].
    Fortschr Med Suppl; 1991; 112():1-15. PubMed ID: 9260314
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lipid status in the physician's laboratory].
    Drexel H
    Ther Umsch; 1995 May; 52(5):340-2. PubMed ID: 7770820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipid metabolism disorders: diagnosis and treatment. 3: Treatment goals--therapy groups--primary hyperlipidemias. Nationale Cholesterin-Initiative].
    Fortschr Med; 1991 May; 109(15):323-4, 325-6. PubMed ID: 1855759
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of atherosclerosis in diabetes: emphasis on treatment for the abnormal lipoprotein metabolism of diabetes.
    Kim DK; Escalante DA; Garber AJ
    Clin Ther; 1993; 15(5):766-78; discussion 765. PubMed ID: 8269443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.